Feasibility of cell therapy for amyotrophic lateral sclerosis.
Garbuzova-Davis
Svitlana
S
Center of Excellence for Aging & Brain Repair, University of South Florida, College of Medicine, Tampa, FL 33612, USA. sgarbuzo@health.usf.edu
Sanberg
Paul R
PR
D000690:Amyotrophic Lateral Sclerosis / Q000378:metabolism / Q000503:physiopathology / Q000628:therapy*; D000818:Animals; D002454:Cell Differentiation / Q000502:physiology*; D019070:Cell Lineage / Q000502:physiology; D004195:Disease Models, Animal; D006085:Graft Survival / Q000502:physiology; D006801:Humans; D007267:Injections / Q000379:methods; D009046:Motor Neurons / Q000166:cytology / Q000502:physiology*; D009414:Nerve Growth Factors / Q000494:pharmacology / Q000627:therapeutic use; D009473:Neuronal Plasticity / Q000502:physiology; D033581:Stem Cell Transplantation / Q000379:methods* / Q000639:trends*; D013234:Stem Cells / Q000166:cytology / Q000502:physiology*
D009414:Nerve Growth Factors